APBA2: A Potential Drug Target Or Biomarker (G321)

Target Name: APBA2

NCBI ID: G321

APBA2

APBA2: A Potential Drug Target Or Biomarker

APBA2 (Alkylator-Protein Binding Adaptase 2) is a protein that is expressed in various tissues throughout the body. It is involved in the detoxification and neutralization of toxic substances, making it an potential drug target or biomarker.

The protein APBA2 has been identified as a potential drug target by its ability to interact with several drug-like molecules, including small molecules, peptides, and even proteins. This interaction with these molecules has led to the conclusion that APBA2 may be a drug target or biomarker for a variety of diseases.

One of the mechanisms through which APBA2 may be involved in drug targeting is its ability to interact with several drug-like molecules that are involved in cellular signaling pathways. For example, studies have shown that APBA2 can interact with molecules such as P-gp, a protein that is involved in the detoxification of drugs. This interaction may make APBA2 a drug-like molecule that can be targeted by drugs that are designed to inhibit its activity.

Another potential mechanism through which APBA2 may be involved in drug targeting is its role in the detoxification of environmental toxins. Many environmental toxins, such as those found in water and soil, are able to interact with APBA2 and alter its function. This may make APBA2 a useful biomarker for monitoring the effectiveness of drugs designed to detoxify these toxins.

In addition to its potential role as a drug target or biomarker, APBA2 has also been shown to have a variety of other functions in various cellular processes. For example, it is involved in the detoxification of xenobiotics, which are synthetic molecules that are often used in agriculture and have been found to be harmful to human health. This may make APBA2 a potential target for drugs designed to detoxify these molecules.

APBA2 is also involved in the regulation of cellular signaling pathways, which are important for the proper functioning of many cellular processes. This may make it a potential target for drugs that are designed to alter the activity of these pathways.

In conclusion, APBA2 is a protein that is expressed in various tissues throughout the body and is involved in a variety of cellular processes. Its interaction with drug-like molecules has led to its potential as a drug target or biomarker for a variety of diseases. Further research is needed to fully understand the role of APBA2 in drug targeting and its potential as a biomarker.

Protein Name: Amyloid Beta Precursor Protein Binding Family A Member 2

Functions: Putative function in synaptic vesicle exocytosis by binding to STXBP1, an essential component of the synaptic vesicle exocytotic machinery. May modulate processing of the amyloid-beta precursor protein (APP) and hence formation of APP-beta

The "APBA2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about APBA2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets